Lixisenatide structure
|
Common Name | Lixisenatide | ||
|---|---|---|---|---|
| CAS Number | 320367-13-3 | Molecular Weight | 4858.49000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C215H347N61O65S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LixisenatideLixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM). Sequence: His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-Lys-Lys-Lys-Lys-Lys-Lys-NH2. |
| Name | lixisenatide |
|---|---|
| Synonym | More Synonyms |
| Description | Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM). Sequence: His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-Lys-Lys-Lys-Lys-Lys-Lys-NH2. |
|---|---|
| Related Catalog | |
| Target |
GLP-1 receptor[1][2]. |
| References |
| Molecular Formula | C215H347N61O65S |
|---|---|
| Molecular Weight | 4858.49000 |
| Exact Mass | 4855.54000 |
| PSA | 2085.46000 |
| LogP | 2.13170 |
| Storage condition | -20°C |
| ZP 10 |
| AVE 0010 |
| ZP10A peptide |
| lixisenatide |
| des-38-proline-exendine-4 (Heloderma suspectum)-(1-39)- peptidylpenta-L-lysyl-L-lysinamide |
| AVE0010 |
| Lyxumia |
| UNII-74O62BB01U |